Sally Stabler
Concepts (824)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin B 12 Deficiency | 62 | 2020 | 77 | 6.730 |
Why?
| | Vitamin B 12 | 60 | 2020 | 127 | 5.750 |
Why?
| | Homocysteine | 79 | 2024 | 151 | 5.150 |
Why?
| | Homocystinuria | 18 | 2024 | 62 | 3.660 |
Why?
| | Folic Acid | 53 | 2026 | 199 | 3.270 |
Why?
| | Methionine | 40 | 2021 | 162 | 2.970 |
Why?
| | Methylmalonic Acid | 54 | 2017 | 65 | 2.880 |
Why?
| | Folic Acid Deficiency | 27 | 2021 | 49 | 2.660 |
Why?
| | Cystathionine beta-Synthase | 17 | 2024 | 65 | 2.120 |
Why?
| | Liver | 29 | 2024 | 1887 | 2.000 |
Why?
| | Betaine | 19 | 2024 | 65 | 1.910 |
Why?
| | S-Adenosylmethionine | 22 | 2020 | 59 | 1.720 |
Why?
| | S-Adenosylhomocysteine | 17 | 2020 | 24 | 1.700 |
Why?
| | Hyperhomocysteinemia | 14 | 2020 | 27 | 1.580 |
Why?
| | Vitamin B Complex | 10 | 2020 | 40 | 1.520 |
Why?
| | Amino Acids, Sulfur | 4 | 2020 | 8 | 1.360 |
Why?
| | Nutritional Status | 8 | 2020 | 354 | 1.030 |
Why?
| | Cysteine | 12 | 2020 | 210 | 1.020 |
Why?
| | Betaine-Homocysteine S-Methyltransferase | 3 | 2019 | 9 | 0.950 |
Why?
| | Taurine | 4 | 2019 | 41 | 0.950 |
Why?
| | Tetrahydrofolates | 2 | 2024 | 16 | 0.920 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2024 | 23 | 0.850 |
Why?
| | Sulfur | 3 | 2020 | 64 | 0.750 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 9 | 2021 | 35 | 0.720 |
Why?
| | Oxidation-Reduction | 5 | 2024 | 1087 | 0.710 |
Why?
| | Choline | 11 | 2017 | 136 | 0.700 |
Why?
| | Dietary Supplements | 15 | 2020 | 576 | 0.690 |
Why?
| | Sulfur Compounds | 1 | 2020 | 8 | 0.660 |
Why?
| | Methionine Adenosyltransferase | 6 | 2020 | 10 | 0.660 |
Why?
| | Anemia | 6 | 2014 | 188 | 0.590 |
Why?
| | Metabolic Diseases | 1 | 2020 | 114 | 0.590 |
Why?
| | Glycine Hydroxymethyltransferase | 7 | 2026 | 16 | 0.590 |
Why?
| | Neural Tube Defects | 5 | 2026 | 65 | 0.580 |
Why?
| | Anemia, Megaloblastic | 6 | 2020 | 9 | 0.500 |
Why?
| | Methylation | 12 | 2020 | 242 | 0.490 |
Why?
| | Cystathionine | 14 | 2012 | 22 | 0.480 |
Why?
| | Diet | 12 | 2013 | 1273 | 0.470 |
Why?
| | Animals | 67 | 2026 | 38058 | 0.460 |
Why?
| | Humans | 163 | 2021 | 144759 | 0.440 |
Why?
| | Iron, Dietary | 1 | 2014 | 23 | 0.430 |
Why?
| | Female | 120 | 2026 | 78271 | 0.430 |
Why?
| | Anemia, Iron-Deficiency | 2 | 2014 | 62 | 0.430 |
Why?
| | Adenosylhomocysteinase | 5 | 2021 | 9 | 0.420 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 4 | 2017 | 18 | 0.410 |
Why?
| | Mice | 35 | 2026 | 18339 | 0.410 |
Why?
| | Aged, 80 and over | 34 | 2017 | 8265 | 0.410 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 4 | 2015 | 24 | 0.410 |
Why?
| | Gas Chromatography-Mass Spectrometry | 16 | 2020 | 131 | 0.400 |
Why?
| | Glutathione | 8 | 2020 | 375 | 0.400 |
Why?
| | Disease Models, Animal | 16 | 2026 | 4557 | 0.380 |
Why?
| | Male | 104 | 2026 | 72315 | 0.380 |
Why?
| | Cognition Disorders | 5 | 2011 | 538 | 0.360 |
Why?
| | Dose-Response Relationship, Drug | 11 | 2020 | 2027 | 0.330 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 4 | 2017 | 8 | 0.330 |
Why?
| | Isoenzymes | 5 | 2012 | 299 | 0.330 |
Why?
| | Frail Elderly | 2 | 2010 | 134 | 0.330 |
Why?
| | Aged | 59 | 2017 | 25913 | 0.330 |
Why?
| | Biomarkers | 19 | 2020 | 4271 | 0.330 |
Why?
| | Metabolism, Inborn Errors | 5 | 2020 | 42 | 0.320 |
Why?
| | Hydrogen Sulfide | 2 | 2020 | 48 | 0.320 |
Why?
| | Receptors, Cell Surface | 3 | 2015 | 377 | 0.310 |
Why?
| | Methylmalonyl-CoA Mutase | 9 | 2017 | 10 | 0.310 |
Why?
| | Uracil | 4 | 2021 | 36 | 0.310 |
Why?
| | Carbon | 3 | 2024 | 203 | 0.310 |
Why?
| | Cystathionine gamma-Lyase | 4 | 2020 | 13 | 0.310 |
Why?
| | Thioctic Acid | 1 | 2009 | 12 | 0.300 |
Why?
| | Thrombosis | 2 | 2011 | 393 | 0.300 |
Why?
| | Abortion, Spontaneous | 1 | 2009 | 115 | 0.290 |
Why?
| | Middle Aged | 57 | 2020 | 35875 | 0.280 |
Why?
| | Vitamin B Deficiency | 1 | 2008 | 1 | 0.280 |
Why?
| | Eubacterium | 1 | 2008 | 3 | 0.280 |
Why?
| | Propionibacterium | 1 | 2008 | 3 | 0.280 |
Why?
| | Adult | 69 | 2020 | 40449 | 0.280 |
Why?
| | Intestinal Absorption | 3 | 2013 | 103 | 0.280 |
Why?
| | DNA | 8 | 2020 | 1463 | 0.280 |
Why?
| | Up-Regulation | 3 | 2017 | 851 | 0.280 |
Why?
| | Acyl Coenzyme A | 5 | 2006 | 31 | 0.260 |
Why?
| | Feces | 3 | 2019 | 513 | 0.260 |
Why?
| | Pregnancy | 17 | 2020 | 7190 | 0.260 |
Why?
| | Diabetic Neuropathies | 2 | 2026 | 99 | 0.250 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2026 | 133 | 0.250 |
Why?
| | Malnutrition | 1 | 2008 | 86 | 0.250 |
Why?
| | Mice, Knockout | 11 | 2026 | 3121 | 0.250 |
Why?
| | Mice, Inbred C57BL | 12 | 2024 | 5992 | 0.250 |
Why?
| | Dietary Services | 2 | 2005 | 2 | 0.250 |
Why?
| | Prevalence | 13 | 2017 | 2834 | 0.250 |
Why?
| | Corrinoids | 2 | 2019 | 7 | 0.240 |
Why?
| | Nutrition Assessment | 1 | 2006 | 92 | 0.240 |
Why?
| | Sulfhydryl Compounds | 4 | 2018 | 189 | 0.240 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2021 | 269 | 0.230 |
Why?
| | Antioxidants | 1 | 2009 | 549 | 0.230 |
Why?
| | Amino Acids | 6 | 2020 | 521 | 0.230 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 7 | 2017 | 18 | 0.230 |
Why?
| | Human papillomavirus 16 | 2 | 2018 | 27 | 0.220 |
Why?
| | Transcobalamins | 3 | 2017 | 3 | 0.220 |
Why?
| | Disease Progression | 3 | 2011 | 2847 | 0.220 |
Why?
| | Vitamin B 6 | 2 | 2003 | 11 | 0.210 |
Why?
| | Geriatrics | 2 | 2003 | 96 | 0.210 |
Why?
| | Administration, Oral | 8 | 2019 | 847 | 0.210 |
Why?
| | Brain Diseases | 2 | 2020 | 152 | 0.210 |
Why?
| | Prostatic Neoplasms | 1 | 2011 | 974 | 0.210 |
Why?
| | Mutation | 11 | 2017 | 4089 | 0.200 |
Why?
| | Maternal Nutritional Physiological Phenomena | 3 | 2015 | 181 | 0.200 |
Why?
| | Rumen | 3 | 2014 | 8 | 0.200 |
Why?
| | Food, Fortified | 4 | 2010 | 44 | 0.200 |
Why?
| | Gestational Age | 3 | 2020 | 975 | 0.200 |
Why?
| | Rats | 18 | 2016 | 5597 | 0.190 |
Why?
| | Methylenetetrahydrofolate Dehydrogenase (NADP) | 2 | 2012 | 2 | 0.190 |
Why?
| | Uterine Artery | 2 | 2020 | 75 | 0.190 |
Why?
| | Apolipoproteins E | 5 | 2013 | 94 | 0.190 |
Why?
| | Neonatal Screening | 2 | 2007 | 178 | 0.180 |
Why?
| | Fetal Blood | 5 | 2013 | 342 | 0.180 |
Why?
| | Hearing Loss | 1 | 2006 | 247 | 0.180 |
Why?
| | Ferredoxin-NADP Reductase | 3 | 2012 | 3 | 0.180 |
Why?
| | Heterozygote | 4 | 2015 | 315 | 0.180 |
Why?
| | Cohort Studies | 11 | 2020 | 5960 | 0.170 |
Why?
| | Nutrition Surveys | 3 | 2011 | 282 | 0.170 |
Why?
| | Metabolic Networks and Pathways | 2 | 2015 | 187 | 0.170 |
Why?
| | Mice, Transgenic | 8 | 2014 | 2182 | 0.170 |
Why?
| | Body Mass Index | 1 | 2009 | 2438 | 0.170 |
Why?
| | Lactation | 4 | 2015 | 192 | 0.170 |
Why?
| | Sulfites | 1 | 2020 | 9 | 0.170 |
Why?
| | Cattle | 3 | 2014 | 1000 | 0.170 |
Why?
| | Polyamines | 1 | 2021 | 42 | 0.160 |
Why?
| | Formate-Tetrahydrofolate Ligase | 2 | 2012 | 2 | 0.160 |
Why?
| | Anemia, Pernicious | 3 | 2013 | 6 | 0.160 |
Why?
| | Liver Diseases, Alcoholic | 3 | 2011 | 97 | 0.160 |
Why?
| | Protein Biosynthesis | 1 | 2004 | 458 | 0.160 |
Why?
| | Fetal Growth Retardation | 2 | 2020 | 587 | 0.160 |
Why?
| | Brazil | 4 | 2009 | 180 | 0.160 |
Why?
| | Global Health | 1 | 2004 | 401 | 0.160 |
Why?
| | Aging | 7 | 2010 | 1966 | 0.160 |
Why?
| | Carrier Proteins | 3 | 2014 | 737 | 0.160 |
Why?
| | Animals, Newborn | 3 | 2007 | 902 | 0.160 |
Why?
| | Polymorphism, Genetic | 4 | 2015 | 612 | 0.160 |
Why?
| | Virus Integration | 2 | 2018 | 69 | 0.160 |
Why?
| | Reference Values | 12 | 2010 | 797 | 0.150 |
Why?
| | Aminobutyrates | 2 | 2018 | 31 | 0.150 |
Why?
| | Erythrocytes | 8 | 2011 | 757 | 0.150 |
Why?
| | Genetic Diseases, Inborn | 2 | 2004 | 44 | 0.150 |
Why?
| | Umbilical Arteries | 1 | 2020 | 52 | 0.150 |
Why?
| | Depressive Disorder | 2 | 2000 | 387 | 0.150 |
Why?
| | Bacteroides | 1 | 2019 | 20 | 0.150 |
Why?
| | Gene Rearrangement | 1 | 2020 | 155 | 0.150 |
Why?
| | Caenorhabditis elegans | 2 | 2017 | 337 | 0.150 |
Why?
| | Isomerases | 3 | 1988 | 8 | 0.140 |
Why?
| | Carnitine | 2 | 1990 | 90 | 0.140 |
Why?
| | Vitamin B 6 Deficiency | 3 | 2011 | 6 | 0.140 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2026 | 2583 | 0.140 |
Why?
| | Infant, Newborn | 14 | 2020 | 6429 | 0.140 |
Why?
| | Sarcosine | 6 | 2012 | 10 | 0.140 |
Why?
| | Genotype | 8 | 2015 | 1833 | 0.140 |
Why?
| | Homozygote | 2 | 2015 | 199 | 0.140 |
Why?
| | Hemophilia B | 2 | 2003 | 66 | 0.140 |
Why?
| | Risk Factors | 15 | 2017 | 10779 | 0.140 |
Why?
| | Liver Diseases | 2 | 2020 | 304 | 0.140 |
Why?
| | Chromatography, Liquid | 4 | 2011 | 454 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2011 | 1217 | 0.140 |
Why?
| | Sulfinic Acids | 1 | 2018 | 6 | 0.140 |
Why?
| | Adolescent | 28 | 2020 | 22428 | 0.140 |
Why?
| | Georgia | 5 | 2013 | 83 | 0.130 |
Why?
| | Mass Spectrometry | 4 | 2017 | 750 | 0.130 |
Why?
| | Geriatric Assessment | 4 | 2013 | 233 | 0.130 |
Why?
| | Infant | 14 | 2015 | 10034 | 0.130 |
Why?
| | Respiratory Hypersensitivity | 1 | 2018 | 65 | 0.130 |
Why?
| | Young Adult | 17 | 2020 | 14105 | 0.130 |
Why?
| | Pyruvaldehyde | 1 | 2018 | 50 | 0.130 |
Why?
| | Racemases and Epimerases | 2 | 2006 | 11 | 0.130 |
Why?
| | Genetic Variation | 2 | 2015 | 983 | 0.130 |
Why?
| | Lymphoma, AIDS-Related | 2 | 1996 | 14 | 0.130 |
Why?
| | Thymidine Monophosphate | 3 | 2013 | 4 | 0.130 |
Why?
| | Phosphatidylcholines | 5 | 2013 | 131 | 0.130 |
Why?
| | Folate Receptor 2 | 1 | 2017 | 7 | 0.130 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2017 | 118 | 0.130 |
Why?
| | Methyltransferases | 5 | 2008 | 74 | 0.130 |
Why?
| | DNA, Mitochondrial | 3 | 2021 | 211 | 0.120 |
Why?
| | ROC Curve | 2 | 2011 | 614 | 0.120 |
Why?
| | Child, Preschool | 17 | 2020 | 11787 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 529 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2015 | 2145 | 0.120 |
Why?
| | Hematinics | 2 | 2006 | 22 | 0.120 |
Why?
| | Thromboembolism | 2 | 2015 | 125 | 0.120 |
Why?
| | Carcinogenesis | 1 | 2018 | 229 | 0.120 |
Why?
| | Crosses, Genetic | 2 | 2013 | 124 | 0.120 |
Why?
| | Propionates | 3 | 2017 | 39 | 0.120 |
Why?
| | Lung | 5 | 2012 | 4109 | 0.120 |
Why?
| | Stomach | 1 | 1996 | 109 | 0.120 |
Why?
| | Diabetic Nephropathies | 1 | 1999 | 318 | 0.120 |
Why?
| | Alleles | 5 | 2009 | 879 | 0.120 |
Why?
| | Hydroxocobalamin | 3 | 1990 | 33 | 0.120 |
Why?
| | Genome | 1 | 2018 | 306 | 0.110 |
Why?
| | Neoplasms, Experimental | 2 | 2017 | 173 | 0.110 |
Why?
| | Linear Models | 5 | 2010 | 854 | 0.110 |
Why?
| | Phospholipids | 1 | 2017 | 213 | 0.110 |
Why?
| | Glycine N-Methyltransferase | 3 | 2011 | 4 | 0.110 |
Why?
| | Keratinocytes | 2 | 2018 | 248 | 0.110 |
Why?
| | Alcoholism | 2 | 2020 | 817 | 0.110 |
Why?
| | Weight Gain | 2 | 2016 | 556 | 0.110 |
Why?
| | Age Factors | 6 | 2010 | 3333 | 0.110 |
Why?
| | Double-Blind Method | 7 | 2015 | 2029 | 0.110 |
Why?
| | Thymidylate Synthase | 2 | 2011 | 13 | 0.110 |
Why?
| | Kidney Failure, Chronic | 2 | 2020 | 598 | 0.110 |
Why?
| | Choline Deficiency | 3 | 2012 | 10 | 0.110 |
Why?
| | Biochemistry | 1 | 2015 | 36 | 0.110 |
Why?
| | Hemophilia A | 2 | 1996 | 147 | 0.110 |
Why?
| | Host Cell Factor C1 | 1 | 2014 | 15 | 0.110 |
Why?
| | Pilot Projects | 3 | 2020 | 1886 | 0.110 |
Why?
| | RNA, Messenger | 6 | 2017 | 2832 | 0.110 |
Why?
| | Milk, Human | 2 | 2015 | 172 | 0.110 |
Why?
| | Micronutrients | 1 | 2015 | 96 | 0.110 |
Why?
| | DNA Methylation | 4 | 2018 | 681 | 0.110 |
Why?
| | Dietary Fats | 1 | 2016 | 314 | 0.110 |
Why?
| | Hemoglobins, Abnormal | 1 | 1994 | 8 | 0.100 |
Why?
| | Placenta | 3 | 2017 | 780 | 0.100 |
Why?
| | Energy Intake | 2 | 2015 | 499 | 0.100 |
Why?
| | Cyanosis | 1 | 1994 | 17 | 0.100 |
Why?
| | Child | 16 | 2020 | 22633 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2020 | 905 | 0.100 |
Why?
| | Blotting, Western | 5 | 2014 | 1187 | 0.100 |
Why?
| | Milk | 1 | 2014 | 119 | 0.100 |
Why?
| | Paresthesia | 2 | 2013 | 14 | 0.100 |
Why?
| | Cross-Sectional Studies | 7 | 2010 | 5868 | 0.100 |
Why?
| | Colitis | 2 | 2019 | 280 | 0.100 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2020 | 682 | 0.100 |
Why?
| | Drosophila melanogaster | 1 | 2015 | 236 | 0.100 |
Why?
| | Women's Health | 3 | 2015 | 310 | 0.100 |
Why?
| | Benzimidazoles | 1 | 2014 | 190 | 0.100 |
Why?
| | Infant Nutrition Disorders | 1 | 2013 | 10 | 0.100 |
Why?
| | Child Nutrition Disorders | 1 | 2013 | 20 | 0.100 |
Why?
| | Time Factors | 7 | 2006 | 7173 | 0.100 |
Why?
| | Analysis of Variance | 5 | 2011 | 1306 | 0.100 |
Why?
| | Malonates | 3 | 1990 | 9 | 0.090 |
Why?
| | Lipid Metabolism | 1 | 2016 | 527 | 0.090 |
Why?
| | Interleukin-1beta | 2 | 2011 | 395 | 0.090 |
Why?
| | Chloroflexi | 1 | 2012 | 12 | 0.090 |
Why?
| | Maternal-Fetal Exchange | 1 | 2013 | 169 | 0.090 |
Why?
| | Apolipoproteins A | 1 | 2012 | 18 | 0.090 |
Why?
| | DNA Mutational Analysis | 3 | 2009 | 406 | 0.090 |
Why?
| | Aryldialkylphosphatase | 1 | 2012 | 17 | 0.090 |
Why?
| | Aminohydrolases | 1 | 2012 | 4 | 0.090 |
Why?
| | Cell Transformation, Viral | 1 | 2012 | 23 | 0.090 |
Why?
| | Gene Expression Regulation | 3 | 2017 | 2608 | 0.090 |
Why?
| | Injections | 1 | 2013 | 196 | 0.090 |
Why?
| | Papillomavirus Infections | 2 | 2018 | 345 | 0.090 |
Why?
| | Apolipoprotein A-I | 1 | 2012 | 39 | 0.090 |
Why?
| | Hemoglobins | 3 | 2011 | 384 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 2 | 2011 | 965 | 0.090 |
Why?
| | Multienzyme Complexes | 1 | 2012 | 67 | 0.090 |
Why?
| | Bone Density | 1 | 2015 | 482 | 0.090 |
Why?
| | Pyridoxine | 3 | 1996 | 37 | 0.090 |
Why?
| | Logistic Models | 4 | 2013 | 2117 | 0.090 |
Why?
| | Diagnostic Errors | 1 | 2013 | 175 | 0.090 |
Why?
| | Fibroblasts | 6 | 2021 | 1034 | 0.090 |
Why?
| | Neurogenesis | 1 | 2013 | 156 | 0.090 |
Why?
| | Prospective Studies | 12 | 2013 | 7990 | 0.090 |
Why?
| | Zebrafish Proteins | 1 | 2014 | 311 | 0.080 |
Why?
| | Vitamins | 3 | 2007 | 178 | 0.080 |
Why?
| | Oxidative Stress | 4 | 2019 | 1339 | 0.080 |
Why?
| | Superoxide Dismutase | 1 | 1993 | 301 | 0.080 |
Why?
| | Cell Nucleus | 2 | 2011 | 618 | 0.080 |
Why?
| | Polymorphism, Restriction Fragment Length | 2 | 2008 | 64 | 0.080 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2011 | 162 | 0.080 |
Why?
| | Mutation, Missense | 4 | 2009 | 340 | 0.080 |
Why?
| | Nutritional Requirements | 2 | 2010 | 76 | 0.080 |
Why?
| | Hydrops Fetalis | 1 | 2010 | 13 | 0.080 |
Why?
| | Memory | 1 | 2013 | 295 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 983 | 0.080 |
Why?
| | Cognition | 2 | 2013 | 1266 | 0.080 |
Why?
| | Pregnancy Complications | 2 | 2009 | 592 | 0.080 |
Why?
| | Inflammation | 3 | 2019 | 2878 | 0.080 |
Why?
| | Cell Line | 4 | 2017 | 2882 | 0.080 |
Why?
| | Polymerase Chain Reaction | 3 | 2009 | 1054 | 0.080 |
Why?
| | Coenzyme A | 1 | 1990 | 7 | 0.080 |
Why?
| | Sensitivity and Specificity | 5 | 2009 | 1985 | 0.080 |
Why?
| | Lactams | 1 | 1990 | 28 | 0.080 |
Why?
| | Chemokines | 1 | 2011 | 218 | 0.080 |
Why?
| | RNA-Binding Proteins | 3 | 2017 | 462 | 0.080 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 266 | 0.080 |
Why?
| | Creatinine | 4 | 2011 | 506 | 0.080 |
Why?
| | Mice, Nude | 3 | 2018 | 682 | 0.080 |
Why?
| | Hematocrit | 4 | 2002 | 108 | 0.080 |
Why?
| | Proportional Hazards Models | 2 | 2011 | 1325 | 0.080 |
Why?
| | Blood Coagulation | 1 | 2011 | 268 | 0.080 |
Why?
| | Siblings | 1 | 2010 | 195 | 0.080 |
Why?
| | Leukocytes | 2 | 2015 | 295 | 0.080 |
Why?
| | Educational Status | 2 | 2003 | 467 | 0.070 |
Why?
| | Mitochondrial Proteins | 1 | 2011 | 262 | 0.070 |
Why?
| | Gastrointestinal Contents | 1 | 2009 | 8 | 0.070 |
Why?
| | Treatment Outcome | 8 | 2013 | 11679 | 0.070 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1499 | 0.070 |
Why?
| | Endothelium, Vascular | 2 | 2006 | 965 | 0.070 |
Why?
| | Antibodies, Bacterial | 1 | 2010 | 148 | 0.070 |
Why?
| | Formates | 1 | 2008 | 16 | 0.070 |
Why?
| | Kidney | 2 | 2007 | 1495 | 0.070 |
Why?
| | Atherosclerosis | 1 | 2013 | 409 | 0.070 |
Why?
| | Glutamate Carboxypeptidase II | 1 | 2008 | 8 | 0.070 |
Why?
| | Neuropsychological Tests | 3 | 2013 | 1134 | 0.070 |
Why?
| | Reduced Folate Carrier Protein | 1 | 2008 | 9 | 0.070 |
Why?
| | Neoplasm Metastasis | 1 | 2011 | 688 | 0.070 |
Why?
| | Deuterium | 3 | 2015 | 100 | 0.070 |
Why?
| | Amino Acid Isomerases | 1 | 1988 | 1 | 0.070 |
Why?
| | Intramolecular Transferases | 1 | 1988 | 3 | 0.070 |
Why?
| | Homeostasis | 2 | 2020 | 640 | 0.070 |
Why?
| | Fatty Liver | 2 | 2010 | 251 | 0.070 |
Why?
| | Biological Availability | 2 | 2010 | 142 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 2168 | 0.070 |
Why?
| | Recurrence | 1 | 2011 | 1135 | 0.070 |
Why?
| | Parity | 1 | 2008 | 109 | 0.070 |
Why?
| | Leucine | 1 | 1988 | 116 | 0.070 |
Why?
| | Folate Receptors, GPI-Anchored | 2 | 2005 | 5 | 0.070 |
Why?
| | Cytoplasm | 1 | 2008 | 269 | 0.070 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2007 | 55 | 0.070 |
Why?
| | Oxygen | 1 | 1993 | 995 | 0.070 |
Why?
| | Promoter Regions, Genetic | 1 | 2012 | 1257 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 3 | 2009 | 2527 | 0.060 |
Why?
| | Lipids | 1 | 2012 | 710 | 0.060 |
Why?
| | Hippocampus | 1 | 2013 | 965 | 0.060 |
Why?
| | Regression Analysis | 2 | 2000 | 1003 | 0.060 |
Why?
| | Socioeconomic Factors | 3 | 2008 | 1326 | 0.060 |
Why?
| | Cobalt | 3 | 2014 | 53 | 0.060 |
Why?
| | Molecular Sequence Data | 5 | 2012 | 2930 | 0.060 |
Why?
| | Muscle, Skeletal | 2 | 2007 | 1795 | 0.060 |
Why?
| | Obesity | 1 | 2020 | 3077 | 0.060 |
Why?
| | Pregnancy Trimester, Third | 2 | 2020 | 115 | 0.060 |
Why?
| | Succinates | 4 | 1991 | 24 | 0.060 |
Why?
| | Base Sequence | 4 | 2015 | 2190 | 0.060 |
Why?
| | Fibrinogens, Abnormal | 1 | 2006 | 3 | 0.060 |
Why?
| | Thrombin Time | 1 | 2006 | 11 | 0.060 |
Why?
| | Afibrinogenemia | 1 | 2006 | 7 | 0.060 |
Why?
| | Smoking | 2 | 2012 | 1472 | 0.060 |
Why?
| | Succinic Acid | 4 | 1991 | 42 | 0.060 |
Why?
| | Diagnosis, Differential | 4 | 2006 | 1489 | 0.060 |
Why?
| | Cardiotonic Agents | 1 | 2006 | 95 | 0.060 |
Why?
| | Cobamides | 1 | 2006 | 25 | 0.060 |
Why?
| | Iron | 2 | 2008 | 359 | 0.060 |
Why?
| | Reproduction | 1 | 2007 | 207 | 0.060 |
Why?
| | Social Class | 2 | 2005 | 268 | 0.060 |
Why?
| | Mitochondria | 3 | 2021 | 984 | 0.060 |
Why?
| | Acquired Immunodeficiency Syndrome | 3 | 1999 | 235 | 0.060 |
Why?
| | Homocystine | 1 | 2005 | 1 | 0.060 |
Why?
| | Dextran Sulfate | 2 | 2019 | 92 | 0.060 |
Why?
| | Oncogene Proteins, Viral | 2 | 2018 | 20 | 0.060 |
Why?
| | von Willebrand Factor | 2 | 2006 | 85 | 0.060 |
Why?
| | Severity of Illness Index | 5 | 2011 | 2925 | 0.060 |
Why?
| | Ganglia, Spinal | 1 | 2026 | 88 | 0.060 |
Why?
| | Disulfides | 2 | 2008 | 96 | 0.060 |
Why?
| | Recommended Dietary Allowances | 2 | 2015 | 16 | 0.060 |
Why?
| | Acidosis | 1 | 2006 | 105 | 0.060 |
Why?
| | Transfection | 2 | 2006 | 940 | 0.060 |
Why?
| | Brain Edema | 2 | 2003 | 62 | 0.060 |
Why?
| | Membrane Proteins | 1 | 2011 | 1166 | 0.060 |
Why?
| | Fetus | 2 | 2012 | 803 | 0.060 |
Why?
| | Food Services | 1 | 2005 | 21 | 0.050 |
Why?
| | Zinc | 1 | 2008 | 295 | 0.050 |
Why?
| | Apoptosis | 2 | 2012 | 2430 | 0.050 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1560 | 0.050 |
Why?
| | Kidney Diseases | 2 | 2007 | 427 | 0.050 |
Why?
| | Epidemiologic Methods | 1 | 2005 | 89 | 0.050 |
Why?
| | Hyperoxia | 1 | 2005 | 99 | 0.050 |
Why?
| | Gene Expression | 3 | 2018 | 1490 | 0.050 |
Why?
| | Mass Screening | 3 | 2002 | 1347 | 0.050 |
Why?
| | Biomarkers, Tumor | 1 | 2011 | 1313 | 0.050 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2018 | 267 | 0.050 |
Why?
| | Diet, Vegetarian | 1 | 2004 | 10 | 0.050 |
Why?
| | Indicator Dilution Techniques | 1 | 2003 | 12 | 0.050 |
Why?
| | Carotid Stenosis | 1 | 2005 | 102 | 0.050 |
Why?
| | Liver Cirrhosis | 2 | 2010 | 288 | 0.050 |
Why?
| | Menopause | 1 | 2007 | 320 | 0.050 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2006 | 210 | 0.050 |
Why?
| | 5' Untranslated Regions | 1 | 2004 | 59 | 0.050 |
Why?
| | Brain | 5 | 2012 | 2933 | 0.050 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 676 | 0.050 |
Why?
| | Hemorrhage | 2 | 2006 | 809 | 0.050 |
Why?
| | Fasting | 5 | 2004 | 277 | 0.050 |
Why?
| | Arginine | 1 | 2005 | 262 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2001 | 163 | 0.050 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2008 | 428 | 0.050 |
Why?
| | Sex Factors | 3 | 2010 | 2112 | 0.050 |
Why?
| | Postoperative Complications | 1 | 1996 | 2919 | 0.050 |
Why?
| | Testosterone | 1 | 2007 | 419 | 0.050 |
Why?
| | Neoplasms | 2 | 2018 | 2875 | 0.050 |
Why?
| | Epithelial Cells | 2 | 2008 | 1125 | 0.050 |
Why?
| | Factor IX | 1 | 2003 | 51 | 0.050 |
Why?
| | Mental Disorders | 3 | 1998 | 1168 | 0.050 |
Why?
| | Nutritional Support | 1 | 2003 | 39 | 0.050 |
Why?
| | Infant Food | 1 | 2003 | 64 | 0.050 |
Why?
| | Protein Binding | 2 | 2012 | 2273 | 0.050 |
Why?
| | Kinetics | 6 | 2007 | 1627 | 0.050 |
Why?
| | Smoke | 1 | 2004 | 148 | 0.050 |
Why?
| | Mutagenesis, Insertional | 2 | 2012 | 64 | 0.050 |
Why?
| | Connective Tissue | 1 | 2002 | 39 | 0.050 |
Why?
| | Lyases | 1 | 2002 | 16 | 0.050 |
Why?
| | Brachial Artery | 2 | 2019 | 206 | 0.050 |
Why?
| | Glutamates | 1 | 2002 | 66 | 0.050 |
Why?
| | HeLa Cells | 1 | 2004 | 650 | 0.040 |
Why?
| | Mice, Mutant Strains | 2 | 2012 | 299 | 0.040 |
Why?
| | Cell Line, Tumor | 3 | 2005 | 3540 | 0.040 |
Why?
| | Guanine | 1 | 2002 | 87 | 0.040 |
Why?
| | Purpura, Thrombotic Thrombocytopenic | 1 | 2001 | 14 | 0.040 |
Why?
| | Metalloendopeptidases | 1 | 2001 | 62 | 0.040 |
Why?
| | Phenotype | 4 | 2014 | 3162 | 0.040 |
Why?
| | Vascular Diseases | 3 | 2004 | 251 | 0.040 |
Why?
| | Pyridoxal Phosphate | 2 | 2011 | 25 | 0.040 |
Why?
| | Methotrexate | 2 | 2015 | 240 | 0.040 |
Why?
| | Down-Regulation | 1 | 2004 | 627 | 0.040 |
Why?
| | Birth Weight | 1 | 2004 | 522 | 0.040 |
Why?
| | Surveys and Questionnaires | 4 | 2015 | 6048 | 0.040 |
Why?
| | Molecular Weight | 5 | 1988 | 327 | 0.040 |
Why?
| | Malonyl Coenzyme A | 3 | 1990 | 5 | 0.040 |
Why?
| | Respiration | 1 | 2021 | 206 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2000 | 7 | 0.040 |
Why?
| | New York | 2 | 2015 | 125 | 0.040 |
Why?
| | Antigens, CD | 2 | 2001 | 555 | 0.040 |
Why?
| | Papio | 1 | 2000 | 85 | 0.040 |
Why?
| | Citrates | 3 | 1998 | 41 | 0.040 |
Why?
| | Anemia, Macrocytic | 1 | 2000 | 4 | 0.040 |
Why?
| | Models, Biological | 4 | 2012 | 1821 | 0.040 |
Why?
| | Case-Control Studies | 5 | 2010 | 3604 | 0.040 |
Why?
| | Pregnancy Outcome | 2 | 2020 | 476 | 0.040 |
Why?
| | Neurocognitive Disorders | 2 | 1992 | 33 | 0.040 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2000 | 87 | 0.040 |
Why?
| | Sampling Studies | 1 | 2000 | 99 | 0.040 |
Why?
| | Coronary Artery Disease | 1 | 2006 | 741 | 0.040 |
Why?
| | Genetic Testing | 1 | 2003 | 478 | 0.040 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2001 | 278 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1994 | 594 | 0.040 |
Why?
| | Odds Ratio | 3 | 2002 | 1075 | 0.040 |
Why?
| | Oncogenes | 1 | 2020 | 119 | 0.040 |
Why?
| | Parenteral Nutrition | 1 | 2000 | 105 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1370 | 0.040 |
Why?
| | Blotting, Northern | 3 | 2007 | 204 | 0.040 |
Why?
| | Embryo, Mammalian | 1 | 2020 | 232 | 0.040 |
Why?
| | Nervous System Diseases | 2 | 1996 | 284 | 0.040 |
Why?
| | Cecum | 1 | 2019 | 37 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 126 | 0.040 |
Why?
| | Species Specificity | 2 | 2007 | 574 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2003 | 441 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 109 | 0.040 |
Why?
| | Kidney Function Tests | 1 | 1999 | 157 | 0.040 |
Why?
| | Reticulocyte Count | 2 | 2000 | 7 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 331 | 0.040 |
Why?
| | Pancytopenia | 1 | 1999 | 7 | 0.040 |
Why?
| | Fatty Acids, Volatile | 1 | 2019 | 60 | 0.040 |
Why?
| | Stroke | 2 | 2005 | 1256 | 0.040 |
Why?
| | Metabolomics | 2 | 2017 | 727 | 0.040 |
Why?
| | Income | 1 | 1999 | 202 | 0.040 |
Why?
| | Albuminuria | 1 | 1999 | 190 | 0.030 |
Why?
| | Nutrition Policy | 2 | 2010 | 58 | 0.030 |
Why?
| | RNA | 2 | 2004 | 940 | 0.030 |
Why?
| | Papillomavirus E7 Proteins | 1 | 2018 | 11 | 0.030 |
Why?
| | Oligodendroglia | 1 | 2000 | 187 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2000 | 255 | 0.030 |
Why?
| | Cross-Over Studies | 2 | 2014 | 601 | 0.030 |
Why?
| | gamma-Glutamyltransferase | 1 | 2018 | 42 | 0.030 |
Why?
| | Pedigree | 2 | 2001 | 514 | 0.030 |
Why?
| | Tissue Distribution | 2 | 2011 | 327 | 0.030 |
Why?
| | Estrogens | 1 | 2020 | 380 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 294 | 0.030 |
Why?
| | Exons | 2 | 2011 | 358 | 0.030 |
Why?
| | Central Nervous System Diseases | 1 | 1998 | 74 | 0.030 |
Why?
| | Aspartate Aminotransferases | 2 | 2011 | 85 | 0.030 |
Why?
| | Lysosomes | 1 | 2017 | 128 | 0.030 |
Why?
| | Acetylcysteine | 2 | 2010 | 139 | 0.030 |
Why?
| | Cytosol | 1 | 2017 | 227 | 0.030 |
Why?
| | History, 20th Century | 2 | 2015 | 325 | 0.030 |
Why?
| | Alanine Transaminase | 2 | 2011 | 151 | 0.030 |
Why?
| | Alcohol Drinking | 2 | 2001 | 826 | 0.030 |
Why?
| | Angina Pectoris | 1 | 1997 | 75 | 0.030 |
Why?
| | 3T3-L1 Cells | 1 | 2016 | 36 | 0.030 |
Why?
| | Chronic Disease | 2 | 2011 | 1813 | 0.030 |
Why?
| | Enzyme Activation | 3 | 2005 | 766 | 0.030 |
Why?
| | Biological Transport | 1 | 2017 | 417 | 0.030 |
Why?
| | Anti-HIV Agents | 2 | 2001 | 888 | 0.030 |
Why?
| | L-Lactate Dehydrogenase | 2 | 2000 | 115 | 0.030 |
Why?
| | Fatal Outcome | 2 | 2010 | 307 | 0.030 |
Why?
| | United States | 3 | 2020 | 15966 | 0.030 |
Why?
| | Denmark | 1 | 2015 | 50 | 0.030 |
Why?
| | Cells, Cultured | 3 | 2012 | 4154 | 0.030 |
Why?
| | Glomerular Filtration Rate | 2 | 2011 | 760 | 0.030 |
Why?
| | Sulfaquinoxaline | 1 | 2015 | 1 | 0.030 |
Why?
| | Food, Formulated | 1 | 2015 | 15 | 0.030 |
Why?
| | Carbon Cycle | 1 | 2015 | 14 | 0.030 |
Why?
| | Body Weight | 2 | 2011 | 976 | 0.030 |
Why?
| | Hematologic Diseases | 1 | 1996 | 66 | 0.030 |
Why?
| | Quantitative Trait Loci | 1 | 2018 | 374 | 0.030 |
Why?
| | HIV Infections | 2 | 2001 | 3154 | 0.030 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1996 | 124 | 0.030 |
Why?
| | Enzyme Induction | 1 | 2015 | 88 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 5 | 2006 | 3863 | 0.030 |
Why?
| | Pregnancy Trimester, Second | 1 | 1995 | 82 | 0.030 |
Why?
| | Comorbidity | 1 | 2000 | 1658 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2013 | 2496 | 0.030 |
Why?
| | Hyaline Membrane Disease | 1 | 1994 | 20 | 0.030 |
Why?
| | Omasum | 1 | 2014 | 2 | 0.030 |
Why?
| | Coronary Artery Bypass | 1 | 1997 | 268 | 0.030 |
Why?
| | Parenteral Nutrition, Total | 1 | 1994 | 30 | 0.030 |
Why?
| | Mammary Glands, Human | 1 | 2015 | 67 | 0.030 |
Why?
| | Histones | 1 | 2020 | 669 | 0.030 |
Why?
| | Cricetinae | 2 | 2007 | 303 | 0.030 |
Why?
| | Branchial Region | 1 | 2014 | 37 | 0.030 |
Why?
| | Family Health | 2 | 2006 | 191 | 0.030 |
Why?
| | Cysteine Dioxygenase | 1 | 2014 | 3 | 0.030 |
Why?
| | Fermentation | 1 | 2014 | 32 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2018 | 437 | 0.030 |
Why?
| | Carboxy-Lyases | 1 | 2014 | 10 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2015 | 215 | 0.030 |
Why?
| | Intrinsic Factor | 2 | 2010 | 2 | 0.030 |
Why?
| | Renal Insufficiency | 2 | 1993 | 168 | 0.030 |
Why?
| | Larva | 1 | 2015 | 242 | 0.030 |
Why?
| | Isoelectric Focusing | 1 | 1994 | 30 | 0.030 |
Why?
| | Electrophoresis | 1 | 1994 | 31 | 0.030 |
Why?
| | Metabolome | 1 | 2018 | 384 | 0.030 |
Why?
| | History, 21st Century | 1 | 2015 | 219 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2014 | 96 | 0.030 |
Why?
| | Craniofacial Abnormalities | 1 | 2014 | 76 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 477 | 0.030 |
Why?
| | Radioisotope Dilution Technique | 3 | 1988 | 14 | 0.030 |
Why?
| | Body Patterning | 1 | 2014 | 138 | 0.030 |
Why?
| | Chromatography, Affinity | 3 | 1988 | 85 | 0.030 |
Why?
| | Animal Feed | 2 | 2009 | 53 | 0.030 |
Why?
| | Neural Crest | 1 | 2014 | 126 | 0.030 |
Why?
| | Myocardial Infarction | 2 | 2004 | 1209 | 0.020 |
Why?
| | Mammals | 1 | 2015 | 293 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 336 | 0.020 |
Why?
| | Coronary Disease | 1 | 1996 | 383 | 0.020 |
Why?
| | Follow-Up Studies | 3 | 2015 | 5408 | 0.020 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 1994 | 138 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 341 | 0.020 |
Why?
| | RNA, Viral | 2 | 2012 | 688 | 0.020 |
Why?
| | Litter Size | 1 | 2013 | 18 | 0.020 |
Why?
| | Dentate Gyrus | 1 | 2013 | 40 | 0.020 |
Why?
| | Hydrolysis | 1 | 2013 | 199 | 0.020 |
Why?
| | Blood Glucose | 2 | 2016 | 2327 | 0.020 |
Why?
| | Anti-Bacterial Agents | 2 | 2015 | 1907 | 0.020 |
Why?
| | Avitaminosis | 2 | 2007 | 6 | 0.020 |
Why?
| | Receptors, CCR2 | 1 | 2013 | 39 | 0.020 |
Why?
| | Rats, Inbred F344 | 2 | 1990 | 268 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2014 | 405 | 0.020 |
Why?
| | Tetrachloroethylene | 1 | 2012 | 4 | 0.020 |
Why?
| | Trichloroethylene | 1 | 2012 | 8 | 0.020 |
Why?
| | Tunicamycin | 1 | 2012 | 11 | 0.020 |
Why?
| | Stroke Volume | 1 | 1996 | 651 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2013 | 319 | 0.020 |
Why?
| | Ethylenes | 1 | 2012 | 17 | 0.020 |
Why?
| | Eating | 1 | 2015 | 389 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 1996 | 541 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2012 | 106 | 0.020 |
Why?
| | Lipotropic Agents | 1 | 2012 | 5 | 0.020 |
Why?
| | Cell Differentiation | 2 | 2014 | 2050 | 0.020 |
Why?
| | Protein Denaturation | 1 | 2012 | 75 | 0.020 |
Why?
| | Neurologic Examination | 1 | 1992 | 131 | 0.020 |
Why?
| | Hep G2 Cells | 1 | 2012 | 74 | 0.020 |
Why?
| | HIV Seropositivity | 1 | 1993 | 119 | 0.020 |
Why?
| | Biodegradation, Environmental | 1 | 2012 | 87 | 0.020 |
Why?
| | Sarcoma, Kaposi | 1 | 1993 | 83 | 0.020 |
Why?
| | Embryo Loss | 1 | 2012 | 4 | 0.020 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2012 | 23 | 0.020 |
Why?
| | Genes, Lethal | 1 | 2012 | 30 | 0.020 |
Why?
| | Patient Selection | 1 | 1996 | 719 | 0.020 |
Why?
| | Hypoxanthine | 1 | 2012 | 11 | 0.020 |
Why?
| | Postpartum Period | 1 | 2015 | 365 | 0.020 |
Why?
| | Chondrocytes | 1 | 2014 | 232 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2016 | 652 | 0.020 |
Why?
| | Random Allocation | 1 | 2012 | 363 | 0.020 |
Why?
| | Catalase | 1 | 2012 | 130 | 0.020 |
Why?
| | Factor Analysis, Statistical | 1 | 2013 | 293 | 0.020 |
Why?
| | Lipoproteins | 1 | 2013 | 169 | 0.020 |
Why?
| | S Phase | 1 | 2011 | 80 | 0.020 |
Why?
| | Radioligand Assay | 1 | 2011 | 37 | 0.020 |
Why?
| | Ferritins | 1 | 2011 | 69 | 0.020 |
Why?
| | Necrosis | 1 | 2012 | 244 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2011 | 121 | 0.020 |
Why?
| | Diet, High-Fat | 1 | 2013 | 261 | 0.020 |
Why?
| | Microbiological Techniques | 1 | 2011 | 33 | 0.020 |
Why?
| | Chemokine CCL4 | 1 | 2011 | 31 | 0.020 |
Why?
| | Capsid Proteins | 1 | 2012 | 95 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 2 | 2001 | 41 | 0.020 |
Why?
| | Proteolysis | 1 | 2012 | 173 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2011 | 193 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2012 | 275 | 0.020 |
Why?
| | Breast Feeding | 1 | 2015 | 448 | 0.020 |
Why?
| | Epithelium | 1 | 2012 | 314 | 0.020 |
Why?
| | Chromatography, Ion Exchange | 2 | 1988 | 57 | 0.020 |
Why?
| | Ethanol | 1 | 1996 | 627 | 0.020 |
Why?
| | Chromatography, Gel | 2 | 1988 | 131 | 0.020 |
Why?
| | Nitrous Oxide | 1 | 1991 | 35 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1991 | 321 | 0.020 |
Why?
| | Interleukin-1alpha | 1 | 2011 | 57 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2011 | 86 | 0.020 |
Why?
| | Cholesterol | 1 | 2013 | 406 | 0.020 |
Why?
| | Transgenes | 1 | 2011 | 189 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 771 | 0.020 |
Why?
| | Neuroblastoma | 1 | 2012 | 174 | 0.020 |
Why?
| | Gastrins | 1 | 1990 | 8 | 0.020 |
Why?
| | Mitochondrial Diseases | 1 | 2011 | 93 | 0.020 |
Why?
| | Protein Conformation | 1 | 1994 | 946 | 0.020 |
Why?
| | Reference Standards | 1 | 2011 | 177 | 0.020 |
Why?
| | Serum Albumin | 1 | 2011 | 147 | 0.020 |
Why?
| | Peroxidase | 1 | 2011 | 168 | 0.020 |
Why?
| | Acid Anhydride Hydrolases | 1 | 2010 | 7 | 0.020 |
Why?
| | Placebos | 2 | 2005 | 192 | 0.020 |
Why?
| | Renal Dialysis | 1 | 1995 | 462 | 0.020 |
Why?
| | Tumor Burden | 1 | 2012 | 319 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2013 | 541 | 0.020 |
Why?
| | Hypertension | 1 | 1999 | 1263 | 0.020 |
Why?
| | Macromolecular Substances | 2 | 1988 | 224 | 0.020 |
Why?
| | Mitochondria, Liver | 1 | 1990 | 70 | 0.020 |
Why?
| | Interleukin-17 | 1 | 2011 | 118 | 0.020 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2010 | 19 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2004 | 2637 | 0.020 |
Why?
| | Hydroxybutyrates | 1 | 1990 | 15 | 0.020 |
Why?
| | Staining and Labeling | 1 | 2010 | 151 | 0.020 |
Why?
| | Bilirubin | 1 | 1990 | 97 | 0.020 |
Why?
| | Monocytes | 1 | 2013 | 538 | 0.020 |
Why?
| | Stem Cells | 1 | 2014 | 626 | 0.020 |
Why?
| | Aorta | 1 | 2013 | 429 | 0.020 |
Why?
| | Zebrafish | 1 | 2014 | 528 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2013 | 509 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1994 | 2155 | 0.020 |
Why?
| | Cell Movement | 1 | 2014 | 965 | 0.020 |
Why?
| | Purines | 1 | 2011 | 187 | 0.020 |
Why?
| | Dairying | 1 | 2009 | 12 | 0.020 |
Why?
| | Helicobacter pylori | 1 | 2010 | 45 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 1991 | 570 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2012 | 744 | 0.020 |
Why?
| | Mexican Americans | 1 | 2010 | 114 | 0.020 |
Why?
| | Fear | 1 | 2013 | 366 | 0.020 |
Why?
| | Hemostasis | 1 | 2010 | 102 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 758 | 0.020 |
Why?
| | Nigeria | 1 | 2009 | 24 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2011 | 309 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2012 | 375 | 0.020 |
Why?
| | Burkitt Lymphoma | 1 | 1989 | 62 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2011 | 416 | 0.020 |
Why?
| | Osteosarcoma | 1 | 1989 | 76 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2013 | 1126 | 0.020 |
Why?
| | Acetylcarnitine | 1 | 1988 | 6 | 0.020 |
Why?
| | Muscles | 1 | 1990 | 333 | 0.020 |
Why?
| | Peroxides | 1 | 2008 | 19 | 0.020 |
Why?
| | Body Composition | 1 | 2013 | 706 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2012 | 371 | 0.020 |
Why?
| | Bacteria | 1 | 2015 | 889 | 0.020 |
Why?
| | Microchemistry | 1 | 1988 | 19 | 0.020 |
Why?
| | Duodenum | 1 | 2009 | 77 | 0.020 |
Why?
| | Isoleucine | 1 | 1988 | 15 | 0.020 |
Why?
| | Silicon | 1 | 1988 | 22 | 0.020 |
Why?
| | Amino Acids, Branched-Chain | 1 | 1988 | 39 | 0.020 |
Why?
| | Catalytic Domain | 1 | 2009 | 232 | 0.020 |
Why?
| | Multivariate Analysis | 2 | 2002 | 1539 | 0.020 |
Why?
| | Ethiopia | 1 | 2008 | 44 | 0.020 |
Why?
| | Health Status Disparities | 1 | 2011 | 321 | 0.020 |
Why?
| | Predictive Value of Tests | 3 | 2000 | 2115 | 0.020 |
Why?
| | Blood Coagulation Disorders | 1 | 2010 | 189 | 0.020 |
Why?
| | Tritium | 1 | 1988 | 68 | 0.020 |
Why?
| | Biopsy | 1 | 2011 | 1075 | 0.020 |
Why?
| | Haplotypes | 1 | 2010 | 490 | 0.020 |
Why?
| | Thiolester Hydrolases | 1 | 1988 | 13 | 0.020 |
Why?
| | Ileum | 1 | 2009 | 111 | 0.020 |
Why?
| | Zea mays | 1 | 2008 | 43 | 0.020 |
Why?
| | Alzheimer Disease | 1 | 1994 | 621 | 0.020 |
Why?
| | Valine | 1 | 1988 | 80 | 0.020 |
Why?
| | Ambulatory Care | 1 | 1992 | 600 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2008 | 250 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2011 | 576 | 0.020 |
Why?
| | Pyrimidines | 1 | 2011 | 532 | 0.020 |
Why?
| | Fibrosis | 1 | 2010 | 548 | 0.020 |
Why?
| | Embryonic Development | 1 | 2008 | 125 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 389 | 0.020 |
Why?
| | Kidney Cortex | 1 | 2007 | 27 | 0.020 |
Why?
| | Guanidinoacetate N-Methyltransferase | 1 | 2007 | 4 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2007 | 159 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2013 | 684 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2011 | 780 | 0.020 |
Why?
| | Infusions, Intravenous | 2 | 2003 | 423 | 0.020 |
Why?
| | Prenatal Care | 1 | 2009 | 307 | 0.020 |
Why?
| | Ambulatory Care Facilities | 1 | 2009 | 265 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2006 | 66 | 0.020 |
Why?
| | Creatine | 1 | 2007 | 63 | 0.020 |
Why?
| | Injections, Intramuscular | 2 | 1998 | 141 | 0.020 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2006 | 31 | 0.020 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1989 | 293 | 0.020 |
Why?
| | von Willebrand Diseases | 1 | 2006 | 28 | 0.020 |
Why?
| | Rabbits | 1 | 2007 | 648 | 0.010 |
Why?
| | Public Health | 1 | 2011 | 566 | 0.010 |
Why?
| | Gene Frequency | 1 | 2007 | 481 | 0.010 |
Why?
| | Dicarboxylic Acids | 1 | 1985 | 10 | 0.010 |
Why?
| | Respiratory Mucosa | 1 | 2008 | 322 | 0.010 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2010 | 419 | 0.010 |
Why?
| | Muscular Diseases | 1 | 2006 | 108 | 0.010 |
Why?
| | Models, Genetic | 1 | 2008 | 536 | 0.010 |
Why?
| | Edible Grain | 1 | 2005 | 49 | 0.010 |
Why?
| | Croatia | 1 | 2005 | 4 | 0.010 |
Why?
| | Transaminases | 1 | 2005 | 22 | 0.010 |
Why?
| | Dipeptides | 1 | 2005 | 57 | 0.010 |
Why?
| | HIV-1 | 2 | 2001 | 896 | 0.010 |
Why?
| | Creatine Kinase | 1 | 2005 | 72 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2005 | 87 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1982 | 0.010 |
Why?
| | RNA Interference | 1 | 2006 | 476 | 0.010 |
Why?
| | New York City | 1 | 2004 | 89 | 0.010 |
Why?
| | tert-Butylhydroperoxide | 1 | 2004 | 9 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2007 | 1253 | 0.010 |
Why?
| | Metals | 1 | 1985 | 142 | 0.010 |
Why?
| | Apolipoprotein E4 | 1 | 2004 | 41 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2011 | 17066 | 0.010 |
Why?
| | Neurons | 1 | 2013 | 1640 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2005 | 919 | 0.010 |
Why?
| | Models, Molecular | 1 | 2009 | 1618 | 0.010 |
Why?
| | Psychological Tests | 1 | 2004 | 132 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2005 | 413 | 0.010 |
Why?
| | Hemostasis, Surgical | 1 | 2003 | 27 | 0.010 |
Why?
| | Depression | 1 | 2013 | 1558 | 0.010 |
Why?
| | Myelin Sheath | 1 | 2005 | 168 | 0.010 |
Why?
| | Hepatocytes | 1 | 2004 | 223 | 0.010 |
Why?
| | Inactivation, Metabolic | 1 | 2002 | 9 | 0.010 |
Why?
| | Ascorbic Acid | 1 | 2004 | 180 | 0.010 |
Why?
| | Colorado | 1 | 1992 | 4564 | 0.010 |
Why?
| | Enzyme Stability | 1 | 2002 | 73 | 0.010 |
Why?
| | Pemetrexed | 1 | 2002 | 38 | 0.010 |
Why?
| | Drug Contamination | 1 | 2002 | 52 | 0.010 |
Why?
| | Cricetulus | 1 | 2002 | 118 | 0.010 |
Why?
| | Citrate (si)-Synthase | 2 | 1993 | 57 | 0.010 |
Why?
| | Autoantibodies | 1 | 2010 | 1501 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2005 | 630 | 0.010 |
Why?
| | Carcinoma | 1 | 2004 | 228 | 0.010 |
Why?
| | Physical Chromosome Mapping | 1 | 2001 | 20 | 0.010 |
Why?
| | Brain Death | 1 | 2002 | 60 | 0.010 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2001 | 36 | 0.010 |
Why?
| | Hepatomegaly | 1 | 2001 | 4 | 0.010 |
Why?
| | Sex Characteristics | 1 | 2007 | 790 | 0.010 |
Why?
| | Transcription Factors | 1 | 2010 | 1741 | 0.010 |
Why?
| | Vasodilation | 1 | 2005 | 523 | 0.010 |
Why?
| | Radiography | 1 | 2004 | 844 | 0.010 |
Why?
| | Computational Biology | 1 | 2006 | 680 | 0.010 |
Why?
| | Hypertension, Renal | 1 | 2001 | 15 | 0.010 |
Why?
| | Treatment Refusal | 1 | 2002 | 98 | 0.010 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2003 | 149 | 0.010 |
Why?
| | Coffee | 1 | 2001 | 15 | 0.010 |
Why?
| | Tea | 1 | 2001 | 17 | 0.010 |
Why?
| | Kidney Transplantation | 1 | 2007 | 704 | 0.010 |
Why?
| | Multigene Family | 1 | 2001 | 204 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2003 | 779 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2005 | 1716 | 0.010 |
Why?
| | Chromatography, Gas | 1 | 2000 | 32 | 0.010 |
Why?
| | Cell Survival | 1 | 2004 | 1098 | 0.010 |
Why?
| | Bone Marrow Diseases | 1 | 2000 | 20 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2001 | 510 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 2002 | 348 | 0.010 |
Why?
| | Liver Transplantation | 1 | 2007 | 823 | 0.010 |
Why?
| | Culture Media, Conditioned | 1 | 2000 | 111 | 0.010 |
Why?
| | Platelet Count | 1 | 2000 | 96 | 0.010 |
Why?
| | Ultrasonography | 1 | 2004 | 770 | 0.010 |
Why?
| | Kynurenine | 1 | 2000 | 114 | 0.010 |
Why?
| | Leukocyte Count | 1 | 2000 | 316 | 0.010 |
Why?
| | Probability | 1 | 2000 | 310 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2000 | 427 | 0.010 |
Why?
| | Hypersplenism | 1 | 1999 | 9 | 0.010 |
Why?
| | Rats, Wistar | 1 | 2000 | 451 | 0.010 |
Why?
| | Tryptophan | 1 | 2000 | 181 | 0.010 |
Why?
| | Zimbabwe | 1 | 1999 | 76 | 0.010 |
Why?
| | Anemia, Aplastic | 1 | 1999 | 42 | 0.010 |
Why?
| | Life Style | 1 | 2001 | 479 | 0.010 |
Why?
| | Incidence | 1 | 2005 | 2879 | 0.010 |
Why?
| | Chromatography, DEAE-Cellulose | 2 | 1988 | 12 | 0.010 |
Why?
| | Carbon Radioisotopes | 2 | 1988 | 29 | 0.010 |
Why?
| | Viral Load | 1 | 2000 | 526 | 0.010 |
Why?
| | Indicators and Reagents | 2 | 1988 | 106 | 0.010 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2000 | 257 | 0.010 |
Why?
| | Demyelinating Diseases | 1 | 1998 | 84 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 854 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2000 | 1047 | 0.010 |
Why?
| | Drug Overdose | 1 | 2002 | 370 | 0.010 |
Why?
| | Antihypertensive Agents | 1 | 2001 | 510 | 0.010 |
Why?
| | Genes | 1 | 1996 | 226 | 0.010 |
Why?
| | Theophylline | 1 | 1996 | 41 | 0.010 |
Why?
| | Leukemia | 1 | 1999 | 245 | 0.010 |
Why?
| | Deoxyuracil Nucleotides | 1 | 1996 | 4 | 0.010 |
Why?
| | Thymine Nucleotides | 1 | 1996 | 19 | 0.010 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 1996 | 49 | 0.010 |
Why?
| | Diet Surveys | 1 | 1996 | 91 | 0.010 |
Why?
| | Swine, Miniature | 1 | 1996 | 89 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 1030 | 0.010 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 1996 | 130 | 0.010 |
Why?
| | Bronchodilator Agents | 1 | 1996 | 182 | 0.010 |
Why?
| | Age of Onset | 1 | 1996 | 551 | 0.010 |
Why?
| | Wounds and Injuries | 1 | 2003 | 956 | 0.010 |
Why?
| | Autopsy | 1 | 1994 | 94 | 0.010 |
Why?
| | Radioimmunoassay | 1 | 1994 | 165 | 0.010 |
Why?
| | Cell Division | 1 | 1996 | 766 | 0.010 |
Why?
| | Chromatography | 1 | 1993 | 27 | 0.010 |
Why?
| | Belgium | 1 | 1993 | 11 | 0.010 |
Why?
| | Treatment Failure | 1 | 1995 | 365 | 0.010 |
Why?
| | Massachusetts | 1 | 1994 | 180 | 0.010 |
Why?
| | Netherlands | 1 | 1993 | 82 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2002 | 2363 | 0.010 |
Why?
| | Stereoisomerism | 1 | 1993 | 104 | 0.010 |
Why?
| | Germany | 1 | 1993 | 138 | 0.010 |
Why?
| | Swine | 1 | 1996 | 833 | 0.010 |
Why?
| | Blood Chemical Analysis | 1 | 1993 | 109 | 0.010 |
Why?
| | Culture Media | 1 | 1993 | 161 | 0.010 |
Why?
| | Borohydrides | 1 | 1991 | 1 | 0.010 |
Why?
| | Mercaptoethanol | 1 | 1991 | 9 | 0.010 |
Why?
| | Plasma | 1 | 1993 | 225 | 0.010 |
Why?
| | Spectrum Analysis | 1 | 1991 | 93 | 0.010 |
Why?
| | Glutamate Dehydrogenase | 1 | 1990 | 4 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2002 | 2194 | 0.010 |
Why?
| | Succinate Dehydrogenase | 1 | 1990 | 57 | 0.010 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 1990 | 49 | 0.010 |
Why?
| | Molecular Structure | 1 | 1991 | 499 | 0.000 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 1994 | 383 | 0.000 |
Why?
| | Glucose | 1 | 1994 | 1047 | 0.000 |
Why?
| | Light | 1 | 1991 | 411 | 0.000 |
Why?
| | Erythrocyte Indices | 1 | 1988 | 33 | 0.000 |
Why?
| | Hypesthesia | 1 | 1988 | 21 | 0.000 |
Why?
| | Ataxia | 1 | 1988 | 69 | 0.000 |
Why?
| | Oxygen Consumption | 1 | 1990 | 724 | 0.000 |
Why?
| | Intestines | 1 | 1990 | 358 | 0.000 |
Why?
| | Celiac Disease | 1 | 1990 | 308 | 0.000 |
Why?
| | Algorithms | 1 | 1994 | 1837 | 0.000 |
Why?
| | Models, Theoretical | 1 | 1989 | 582 | 0.000 |
Why?
| | Chemistry | 1 | 1985 | 41 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1985 | 81 | 0.000 |
Why?
| | Proteins | 1 | 1990 | 1021 | 0.000 |
Why?
| | Asthma | 1 | 1996 | 1767 | 0.000 |
Why?
|
|
Stabler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|